Dynavax (DVAX) Stock Forecast, Price Target & Predictions
DVAX Stock Forecast
Dynavax stock forecast is as follows: an average price target of $24.50 (represents a 98.22% upside from DVAX’s last price of $12.36) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
DVAX Price Target
DVAX Analyst Ratings
Buy
Dynavax Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jun 28, 2024 | Edward White | H.C. Wainwright | $29.00 | $11.37 | 155.06% | 134.63% |
May 14, 2024 | Paul Choi | Goldman Sachs | $20.00 | $11.00 | 81.82% | 61.81% |
10
Dynavax Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 2 |
Avg Price Target | - | - | $24.50 |
Last Closing Price | $12.36 | $12.36 | $12.36 |
Upside/Downside | -100.00% | -100.00% | 98.22% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 15, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Jun 28, 2024 | H.C. Wainwright | Buy | Buy | Hold |
May 14, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
May 14, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Feb 24, 2023 | JMP Securities | Market Outperform | Market Outperform | Hold |
Sep 27, 2022 | JMP Securities | - | Outperform | Initialise |
10
Dynavax Financial Forecast
Dynavax Revenue Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $69.51M | $60.25M | $46.92M | $184.49M | $167.74M | $256.46M | $113.99M | $195.07M | $108.27M | $52.77M | $83.33M | $19.55M | $13.41M |
Avg Forecast | $106.32M | $133.66M | $126.67M | $107.33M | $90.49M | $112.42M | $105.29M | $86.89M | $79.70M | $95.01M | $87.00M | $69.83M | $71.71M | $84.17M | $76.04M | $54.98M | $52.73M | $60.30M | $48.39M | $38.58M | $179.60M | $159.41M | $150.99M | $154.29M | $208.87M | $58.22M | $41.60M | $59.11M | $13.06M | $9.44M |
High Forecast | $107.96M | $135.72M | $128.62M | $108.98M | $91.88M | $114.15M | $106.91M | $88.22M | $80.93M | $96.48M | $88.34M | $70.91M | $73.67M | $84.74M | $76.04M | $54.98M | $54.73M | $66.01M | $49.14M | $39.18M | $182.36M | $159.41M | $150.99M | $154.29M | $208.87M | $58.22M | $41.60M | $59.11M | $13.06M | $9.44M |
Low Forecast | $104.36M | $131.20M | $124.34M | $105.35M | $88.82M | $110.35M | $103.35M | $85.29M | $78.23M | $93.26M | $85.40M | $68.54M | $69.74M | $83.60M | $76.04M | $54.98M | $50.71M | $58.29M | $47.50M | $37.87M | $176.29M | $159.41M | $150.99M | $154.29M | $208.87M | $58.22M | $41.60M | $59.11M | $13.06M | $9.44M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.15% | 1.25% | 1.22% | 1.03% | 1.05% | 1.70% | 0.74% | 0.93% | 1.86% | 1.27% | 1.41% | 1.50% | 1.42% |
Forecast
Dynavax EBITDA Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.12M | $-3.40M | $-9.72M | $69.66M | $68.91M | $130.41M | $34.47M | $102.37M | $-24.99M | $9.35M | $7.36M | $-8.90M | $10.94M |
Avg Forecast | $-27.96M | $-35.15M | $-33.31M | $-28.22M | $-23.80M | $-29.56M | $-27.69M | $-22.85M | $-20.96M | $-24.99M | $-22.88M | $-18.36M | $-18.86M | $-22.13M | $-20.00M | $54.67M | $-13.86M | $-15.86M | $-12.73M | $-10.15M | $109.17M | $-37.40M | $-35.43M | $39.29M | $-49.01M | $-13.66M | $-9.76M | $16.56M | $-3.07M | $-2.21M |
High Forecast | $-27.44M | $-34.50M | $-32.70M | $-27.70M | $-23.36M | $-29.02M | $-27.18M | $-22.43M | $-20.57M | $-24.53M | $-22.46M | $-18.02M | $-18.34M | $-21.98M | $-20.00M | $65.61M | $-13.33M | $-15.33M | $-12.49M | $-9.96M | $131.01M | $-37.40M | $-35.43M | $47.15M | $-49.01M | $-13.66M | $-9.76M | $19.88M | $-3.07M | $-2.21M |
Low Forecast | $-28.39M | $-35.69M | $-33.82M | $-28.66M | $-24.16M | $-30.02M | $-28.11M | $-23.20M | $-21.28M | $-25.37M | $-23.23M | $-18.65M | $-19.37M | $-22.28M | $-20.00M | $43.74M | $-14.39M | $-17.36M | $-12.92M | $-10.30M | $87.34M | $-37.40M | $-35.43M | $31.43M | $-49.01M | $-13.66M | $-9.76M | $13.25M | $-3.07M | $-2.21M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.32% | 0.27% | 0.96% | 0.64% | -1.84% | -3.68% | 0.88% | -2.09% | 1.83% | -0.96% | 0.44% | 2.90% | -4.94% |
Forecast
Dynavax Net Income Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $14.29M | $3.43M | $-24.33M | $67.73M | $63.81M | $128.75M | $32.86M | $101.39M | $-28.43M | $4.47M | $891.00K | $-15.47M | $4.40M |
Avg Forecast | $20.53M | $38.76M | $34.66M | $22.46M | $12.55M | $27.45M | $23.31M | $11.66M | $7.74M | $22.71M | $18.06M | $3.61M | $5.88M | $17.54M | $9.99M | $49.53M | $-1.63M | $-5.85M | $-14.37M | $45.03M | $106.41M | $45.83M | $35.14M | $35.60M | $98.86M | $3.86M | $-5.66M | $2.00M | $-37.84M | $-31.41M |
High Forecast | $20.94M | $39.54M | $35.35M | $22.91M | $12.81M | $28.00M | $23.78M | $11.89M | $7.90M | $23.16M | $18.42M | $3.68M | $8.82M | $17.90M | $10.03M | $59.44M | $1.63M | $23.38M | $-14.03M | $54.04M | $127.70M | $45.83M | $35.14M | $42.72M | $98.86M | $3.86M | $-5.66M | $2.41M | $-37.84M | $-31.41M |
Low Forecast | $20.04M | $37.83M | $33.83M | $21.93M | $12.25M | $26.79M | $22.76M | $11.38M | $7.56M | $22.16M | $17.63M | $3.53M | $1.47M | $17.18M | $9.96M | $39.63M | $-4.90M | $-40.92M | $-14.66M | $36.02M | $85.13M | $45.83M | $35.14M | $28.48M | $98.86M | $3.86M | $-5.66M | $1.60M | $-37.84M | $-31.41M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.45% | -0.24% | -0.54% | 0.64% | 1.39% | 3.66% | 0.92% | 1.03% | -7.36% | -0.79% | 0.44% | 0.41% | -0.14% |
Forecast
Dynavax SG&A Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $38.05M | $37.07M | $36.54M | $31.02M | $32.04M | $36.18M | $32.17M | $29.22M | $26.93M | $21.58M | $22.42M | $17.84M | $29.24M |
Avg Forecast | $104.19M | $130.99M | $124.13M | $105.18M | $88.68M | $110.17M | $103.19M | $85.15M | $78.10M | $93.11M | $85.26M | $68.43M | $70.27M | $82.48M | $74.52M | $48.50M | $51.67M | $59.09M | $47.42M | $37.81M | $31.17M | $156.22M | $147.97M | $34.85M | $204.69M | $57.05M | $40.77M | $50.45M | $12.80M | $9.25M |
High Forecast | $105.80M | $133.00M | $126.04M | $106.79M | $90.04M | $111.86M | $104.77M | $86.46M | $79.31M | $94.54M | $86.57M | $69.49M | $72.20M | $83.04M | $74.52M | $58.20M | $53.64M | $64.69M | $48.15M | $38.39M | $37.40M | $156.22M | $147.97M | $41.82M | $204.69M | $57.05M | $40.77M | $60.54M | $12.80M | $9.25M |
Low Forecast | $102.27M | $128.57M | $121.85M | $103.24M | $87.05M | $108.14M | $101.28M | $83.58M | $76.67M | $91.40M | $83.69M | $67.17M | $68.34M | $81.92M | $74.52M | $38.80M | $49.69M | $57.12M | $46.55M | $37.11M | $24.93M | $156.22M | $147.97M | $27.88M | $204.69M | $57.05M | $40.77M | $40.36M | $12.80M | $9.25M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.64% | 0.78% | 0.97% | 1.00% | 0.21% | 0.24% | 0.92% | 0.14% | 0.47% | 0.53% | 0.44% | 1.39% | 3.16% |
Forecast
Dynavax EPS Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.11 | $0.03 | $-0.19 | $0.53 | $0.50 | $1.02 | $0.26 | $0.84 | $-0.24 | $0.04 | $0.01 | $-0.14 | $0.04 |
Avg Forecast | $0.13 | $0.25 | $0.22 | $0.15 | $0.08 | $0.18 | $0.15 | $0.08 | $0.05 | $0.15 | $0.12 | $0.02 | $0.04 | $0.11 | $0.06 | $-0.02 | $-0.01 | $-0.04 | $-0.09 | $-0.13 | $0.41 | $0.30 | $0.23 | $0.28 | $0.64 | $0.03 | $-0.04 | $-0.03 | $-0.24 | $-0.20 |
High Forecast | $0.14 | $0.26 | $0.23 | $0.15 | $0.08 | $0.18 | $0.15 | $0.08 | $0.05 | $0.15 | $0.12 | $0.02 | $0.06 | $0.12 | $0.06 | $-0.02 | $0.01 | $0.15 | $-0.09 | $-0.13 | $0.42 | $0.30 | $0.23 | $0.28 | $0.64 | $0.03 | $-0.04 | $-0.03 | $-0.24 | $-0.20 |
Low Forecast | $0.13 | $0.24 | $0.22 | $0.14 | $0.08 | $0.17 | $0.15 | $0.07 | $0.05 | $0.14 | $0.11 | $0.02 | $0.01 | $0.11 | $0.06 | $-0.02 | $-0.03 | $-0.26 | $-0.09 | $-0.14 | $0.40 | $0.30 | $0.23 | $0.28 | $0.64 | $0.03 | $-0.04 | $-0.03 | $-0.24 | $-0.20 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.91% | -0.29% | 1.43% | 1.29% | 1.69% | 4.48% | 0.93% | 1.31% | -9.60% | -1.09% | -0.40% | 0.57% | -0.20% |
Forecast
Dynavax Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
EBS | Emergent BioSolutions | $9.40 | $51.50 | 447.87% | Buy |
IRWD | Ironwood Pharmaceuticals | $3.34 | $11.67 | 249.40% | Buy |
AQST | Aquestive Therapeutics | $4.51 | $10.25 | 127.27% | Buy |
PCRX | Pacira BioSciences | $17.38 | $35.00 | 101.38% | Hold |
DVAX | Dynavax | $12.36 | $24.50 | 98.22% | Buy |
LNTH | Lantheus | $87.32 | $146.25 | 67.49% | Buy |
AMPH | Amphastar Pharmaceuticals | $44.55 | $66.00 | 48.15% | Buy |
ANIP | ANI Pharmaceuticals | $55.86 | $79.00 | 41.42% | Buy |
COLL | Collegium Pharmaceutical | $30.41 | $40.50 | 33.18% | Buy |
ALKS | Alkermes | $27.70 | $36.38 | 31.34% | Hold |
NBIX | Neurocrine Biosciences | $125.00 | $147.35 | 17.88% | Buy |
ITCI | Intra-Cellular Therapies | $85.45 | $94.50 | 10.59% | Buy |
DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |